India’s drug regulator has flagged a batch of the widely used rabies vaccine Abhayrab as substandard and potentially spurious after it failed a potency test, a government document seen by Reuters shows.
The finding marks the second time in less than two years that concerns have been raised about counterfeit Abhayrab doses in India, a country that reports nearly 6,000 rabies deaths a year and where the vaccine is a frontline defence against the otherwise nearly always fatal infection.
India flags Abhayrab rabies vaccine batch as substandard, probes if spurious
Categories: